Disease / condition
Chronic Hepatitis B clinical trials
Free access to 377 studies10+ countriesUpdated daily55 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
377
Total trials
10+
Countries
10+
Sponsors
55
Recruiting
By phase
N/A110
Phase 492
Phase 264
Phase 152
Phase 334
By status
Completed184
Unknown70
Recruiting55
Not yet recruit...30
Terminated18
Top countries
China130
South Korea39
United States of America21
Taiwan12
New Zealand9
Top sponsors
Gilead Sciences30
Assembly Bioscienc...19
Beijing Ditan Hosp...17
Bristol-Myers Squi...12
Gilead Sciences, I...10
Recent trials
Latest clinical trials for Chronic Hepatitis B
A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection
Assembly Biosciences
NCT06384131Not yet recr...
- Phase
- Phase 1
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Chinese University of Hong Kon... · China
NCT06364930Recruiting
- Phase
- Phase 4
The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients
Beijing 302 Hospital · China
NCT06357806Recruiting
A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance
Qilu Hospital of Shandong Univ... · China
NCT06313255Recruiting
A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
Shanghai Longwood Biopharmaceu... · China
NCT06311734Recruitment ...
- Phase
- Phase 1
Regulation of Intestinal Flora by Compound Probiotics in Patients With Chronic Hepatitis B
Wecare Probiotics Co., Ltd.
NCT06221605Not yet recr...
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Fujian Akeylink Biotechnology ... · China
NCT06263959Recruiting
- Phase
- Phase 2
Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
University of Maryland, Baltim...
NCT06154278Not yet recr...
- Phase
- Phase 2
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
National Institute of Diabetes... · United States of America
NCT06092333Not yet recr...
- Phase
- Phase 2
Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy
Virion Therapeutics · China,New Zealand
NCT06070051Recruiting
- Phase
- Phase 1
A Phase 1, Placebo-controlled, First-in-human Study of Orally Administered DF-006 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Multiple Doses in Chronic Hepatitis B subjects
Zhejiang Yao Yuan Biotechnolog... · New Zealand;China;China;South Korea
ANZCTR12623000997651Not yet recr...
- Phase
- Phase 1
Study to Evaluate the Safety, Tolerability, Immunogenicity and Antiviral Activity of Multiple Doses of CLB-3000 in participants with Chronic Hepatitis B
ClearB Therapeutics, Inc. · Australia
ANZCTR12623000841673Recruiting
- Phase
- Phase 1
A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)
Chengdu Suncadia Medicine Co.,...
NCT05905458Not yet recr...
- Phase
- Phase 2
Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B
Beijing 302 Hospital · China
NCT05905731Not yet recr...
- Phase
- Phase 1
A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors
Huahui Health · China
NCT05839639Not yet recr...
- Phase
- Phase 2
Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B
Fujian Shengdi Pharmaceutical ... · China
NCT05808374Recruiting
- Phase
- Phase 1
A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)
ImmuneMed, Inc. · South Korea
NCT05808335Recruiting
- Phase
- Phase 2
Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B
Gilead Sciences · New Zealand
NCT05770895Recruiting
- Phase
- Phase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection
Hoffmann-La Roche · New Zealand
NCT05763576Recruiting
- Phase
- Phase 1
Efficacy and Safety of TMF in the Treatment of CHB Patients With Low-level Viraemia
The Second Affiliated Hospital... · China
NCT05755776Not yet recr...
About this profile
Access comprehensive clinical trial information for Chronic Hepatitis B through Pure Global AI's free database. This collection includes 377 clinical trials across multiple phases including N/A, Phase 4, Phase 2. Currently, 55 trials are actively recruiting participants.
Research for Chronic Hepatitis B is being conducted in China, South Korea, United States of America and 7+ other countries. Leading sponsors include Gilead Sciences and Assembly Biosciences. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 377 clinical trials studying Chronic Hepatitis B, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Gilead Sciences, Assembly Biosciences, Beijing Ditan Hospital, among others.